Paranagama D, Colucci P, Evans KA, Bonafede M, Parasuraman S. Are patients with high-risk polycythemia vera receiving cytoreductive medications? a retrospective analysis of real-world data. Exp Hematol Oncol. 2018, 7:16. doi: 10.1186/s40164-018-0107-8.
Advertisement
Articles by Paranagama D, Colucci P, Evans KA, Bonafede M, Parasuraman S. Are patients with high-risk polycythemia vera receiving cytoreductive medications? a retrospective analysis of real-world data. Exp Hematol Oncol. 2018, 7:16. doi: 10.1186/s40164-018-0107-8.
Advertisement
Latest Updated Articles
- Study Summary: Real-World Adherence to Cytoreductive Treatment in Polycythemia Vera Is Low
Published: August 28th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
2
Top 5 Most-Read Mental Health Content of 2025
3
Real-World Data Highlight Favorable Responses to Liso-Cel for R/R CLL
4
Baricitinib Shows Real-World Effectiveness in Severe Alopecia Areata Hair Loss
5
